Clinical Trial Update: Study of Thyroid Hormones in Prematures [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating thyroid hormones for Transient Hypothyroxinemia of Prematurity has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transient Hypothyroxinemia of Prematurity

Snippet

Sponsor: New York Medical College | Conditions: Transient Hypothyroxinemia of Prematurity (THOP) | Phase 3 | Status: WITHDRAWN